Published in Pathol Res Pract on July 01, 1996
AR, the cell cycle, and prostate cancer. Nucl Recept Signal (2008) 2.44
FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J (2000) 2.25
Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol Cell Biol (2011) 1.56
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation. Proc Natl Acad Sci U S A (2006) 1.52
A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer. EMBO J (2003) 1.32
Molecular imaging of prostate cancer: PET radiotracers. AJR Am J Roentgenol (2012) 1.22
Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res (2009) 1.17
The cyclin D1b splice variant: an old oncogene learns new tricks. Cell Div (2006) 1.15
Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells. Proc Natl Acad Sci U S A (2005) 1.14
Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol Biol Cell (2002) 1.11
Androgen deprivation by activating the liver X receptor. Endocrinology (2008) 1.10
Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression. Br J Cancer (1999) 1.07
Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer. Int J Biol Sci (2014) 1.07
Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult. Cancer Res (2006) 0.99
Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Environ Health Perspect (2007) 0.95
The AR dependent cell cycle: mechanisms and cancer relevance. Mol Cell Endocrinol (2011) 0.93
Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching. Mol Cell Biol (2012) 0.91
Role of Imaging in Prostate Cancer. PET Clin (2009) 0.81
Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling. Mol Carcinog (2010) 0.81
Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer. Acta Pharmacol Sin (2012) 0.77
The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer. Biomed Res Int (2015) 0.77
Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer. Cancers (Basel) (2017) 0.75
Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer. PLoS One (2016) 0.75
A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun (1990) 3.79
Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol (1991) 2.54
A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab (1998) 2.45
The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol (1992) 2.21
Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem (1996) 2.05
Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem (1995) 2.02
Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol (1999) 1.99
Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol (1994) 1.94
Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells. J Natl Cancer Inst (2000) 1.78
The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol (1991) 1.72
Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet (1997) 1.66
Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun (1988) 1.64
Nuclear import of the human androgen receptor. Biochem J (1993) 1.58
Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry (1992) 1.44
The N-terminal domain of the human androgen receptor is encoded by one, large exon. Mol Cell Endocrinol (1989) 1.38
Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res (1992) 1.34
Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol Endocrinol (1998) 1.26
Epitope prediction and confirmation for the human androgen receptor: generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategy. Biochim Biophys Acta (1991) 1.24
Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry (1997) 1.24
Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol (1992) 1.18
17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab (1999) 1.16
Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol Dis (1997) 1.13
Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res (1997) 1.11
Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. Proc Natl Acad Sci U S A (1990) 1.10
High-affinity binding of oestradiol-17beta by cytosols from testis interstitial tissue, pituitary, adrenal, liver and accessory sex glands of the male rat. Biochem J (1974) 1.09
Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology (2000) 1.09
Steroid hormone receptor phosphorylation: is there a physiological role? Mol Cell Endocrinol (1994) 1.08
Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. J Cell Biochem (1995) 1.07
An exonic point mutation of the androgen receptor gene in a family with complete androgen insensitivity. Am J Hum Genet (1990) 1.06
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. Br J Cancer (2004) 1.06
Characterization of the human androgen receptor transcription unit. J Biol Chem (1991) 1.03
Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. J Biol Chem (1993) 1.03
Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility. Clin Endocrinol (Oxf) (2007) 1.02
Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol (1997) 0.98
Hormone-dependent androgen receptor phosphorylation is accompanied by receptor transformation in human lymph node carcinoma of the prostate cells. J Biol Chem (1991) 0.98
Functional domains of the human androgen receptor. J Steroid Biochem Mol Biol (1992) 0.97
Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry (1994) 0.97
Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells. Endocrinology (1997) 0.97
Structure and function of GC79/TRPS1, a novel androgen-repressible apoptosis gene. Apoptosis (2002) 0.96
Phosphotryptic peptide analysis of the human androgen receptor: detection of a hormone-induced phosphopeptide. Biochemistry (1995) 0.95
Androgen receptor phosphorylation. Endocr Res (1996) 0.94
Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol (1990) 0.93
Structural organization of the human androgen receptor gene. J Mol Endocrinol (1989) 0.93
Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation. Am J Hum Genet (1997) 0.93
Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pre-treatment. J Histochem Cytochem (1994) 0.93
Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet (1993) 0.93
The mouse androgen receptor. Functional analysis of the protein and characterization of the gene. Biochem J (1991) 0.93
Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab (1995) 0.92
Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res (2001) 0.91
Hormonal control of gubernaculum development during testis descent: gubernaculum outgrowth in vitro requires both insulin-like factor and androgen. Endocrinology (2000) 0.91
Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry (1998) 0.91
Differential splicing of human androgen receptor pre-mRNA in X-linked Reifenstein syndrome, because of a deletion involving a putative branch site. Am J Hum Genet (1994) 0.91
Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer (1999) 0.90
Synthesis and post-translational modification of the androgen receptor in LNCaP cells. Mol Cell Endocrinol (1991) 0.88
An oestradiol receptor in rat testis interstitial tissue. FEBS Lett (1972) 0.88
Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome. J Clin Endocrinol Metab (1997) 0.87
Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1 beta, TNF-alpha and LPS. Eur Respir J (1996) 0.87
Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. Biochem J (1993) 0.87
Etiological studies of severe or familial hypospadias. J Urol (2001) 0.87
Androgen receptor heterogeneity in LNCaP cells is caused by a hormone independent phosphorylation step. J Steroid Biochem Mol Biol (1992) 0.87
Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method. Br J Cancer (2000) 0.87
Androgen receptor heterogeneity and phosphorylation in human LNCaP cells. Biochem Biophys Res Commun (1990) 0.86
Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women. Hum Pathol (1994) 0.86
Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clin Endocrinol (Oxf) (1995) 0.86
Binding of oestradiol by the nuclear fraction of rat testis interstitial tissue. FEBS Lett (1973) 0.86
Identification of a gene on human chromosome 8q11 that is differentially expressed during prostate-cancer progression. Int J Cancer (1999) 0.86
Gender differences in expression of androgen receptor in tibial growth plate and metaphyseal bone of the rat. Bone (2002) 0.86
Developmental pattern and regulation by androgens of androgen receptor expression in the urogenital tract of the rat. Mol Cell Endocrinol (1995) 0.86
Natural variants of the beta isoform of the human glucocorticoid receptor do not alter sensitivity to glucocorticoids. Mol Cell Endocrinol (1999) 0.85
Prostate cancer schemes for androgen escape. Nat Med (2000) 0.85
Threonine on amino acid position 868 in the human androgen receptor is essential for androgen binding specificity and functional activity. Biochem Biophys Res Commun (1993) 0.85
Synergism between androgens and protein kinase-C on androgen-regulated gene expression. Mol Cell Endocrinol (1995) 0.85
Analysis of steroid- and DNA-binding domains of the calf uterine androgen receptor by limited proteolysis. J Steroid Biochem (1987) 0.84
The androgen receptor: functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines. J Steroid Biochem Mol Biol (1990) 0.83
Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability. J Clin Endocrinol Metab (2001) 0.82
Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus. J Clin Endocrinol Metab (1998) 0.82
Immunohistochemical localization and immunoblotting of androgen receptor in spinal neurons of male and female rats. Eur J Endocrinol (1996) 0.82
Germ-line and somatic mosaicism in the androgen insensitivity syndrome: implications for genetic counseling. Am J Hum Genet (1997) 0.82
Clinical and molecular spectrum of somatic mosaicism in androgen insensitivity syndrome. Pediatr Res (1999) 0.81
Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881). J Androl (1997) 0.81
Mechanism of androgen action: recent observations on the domain structure of androgen receptors and the induction of EGF-receptors by androgens in prostate tumor cells. J Steroid Biochem (1989) 0.81
Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene. Clin Endocrinol (Oxf) (1996) 0.80
The rat androgen receptor gene promoter. Mol Cell Endocrinol (1990) 0.80
Interaction of steroids with human red blood cells. Ann Endocrinol (Paris) (1970) 0.80
In vitro translation of androgen receptor cRNA results in an activated androgen receptor protein. Biochem J (1993) 0.80
Follicle-stimulating hormone regulates androgen receptor mRNA in Sertoli cells. Mol Cell Endocrinol (1989) 0.79
Substitution of Ala564 in the first zinc cluster of the deoxyribonucleic acid (DNA)-binding domain of the androgen receptor by Asp, Asn, or Leu exerts differential effects on DNA binding. Endocrinology (1998) 0.79
Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value. Gynecol Oncol (2004) 0.79
Decreased immunoreactive androgen receptor levels are not the cause of isolated hypospadias. Br J Urol (1995) 0.78
Effect of testosterone deprivation on expression of the androgen receptor in rat prostate, epididymis and testis. Int J Androl (1992) 0.78
Development and cellular localization of rat testicular aromatase activity. J Reprod Fertil (1982) 0.78
Model studies with erythrocytes on the initial steps of cellular uptake and binding of steroids. J Steroid Biochem (1972) 0.78
Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancer. Eur J Cancer (2002) 0.78
Post-zygotic mutations and somatic mosaicism in androgen insensitivity syndrome. Trends Genet (2001) 0.78
Characterization of androgen receptors after photoaffinity labelling with [3H]methyltrienolone (R1881). J Steroid Biochem (1986) 0.77
Testicular oestrogens. J Endocrinol (1981) 0.77
Molecular basis of androgen insensitivity. J Steroid Biochem Mol Biol (1996) 0.77
Characterization of androgen receptors in a transplantable human prostatic adenocarcinoma (PC-82). Prostate (1987) 0.77
Regulation of androgen receptor expression in the human heterotransplantable prostate carcinoma PC-82. Endocrinology (1992) 0.77
Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome. Eur J Endocrinol (2000) 0.77